Pharmaleads’ mission is to provide precision medicine to relieve the suffering associated with acute and chronic pain. Through the development of our proprietary Dual ENKephalinase Inhibitors (DENKI®) it is our aim to provide both efficacious and safe non-opiate pain therapeutics.
Looking for a particular Pharmaleads employee's phone or email?
The Pharmaleads annual revenue was $8 million in 2026.
Pierre Maillard is the CFO of Pharmaleads.
5 people are employed at Pharmaleads.
Pharmaleads is based in Paris, Ile-de-France.
The NAICS codes for Pharmaleads are [325, 32, 3254, 32541].
The SIC codes for Pharmaleads are [283, 28].